Citigroup set a $102.00 price target on Healthequity (NASDAQ:HQY) in a research report sent to investors on Tuesday. The firm currently has a buy rating on the stock.
A number of other research firms also recently commented on HQY. Zacks Investment Research downgraded Healthequity from a buy rating to a hold rating in a research report on Tuesday, December 18th. Cantor Fitzgerald boosted their price objective on Healthequity from $80.00 to $82.00 and gave the stock a neutral rating in a research note on Thursday, December 6th. ValuEngine cut Healthequity from a buy rating to a hold rating in a research note on Saturday, December 15th. BidaskClub cut Healthequity from a buy rating to a hold rating in a research note on Tuesday, November 20th. Finally, SunTrust Banks cut Healthequity from a buy rating to a hold rating and reduced their price objective for the stock from $105.00 to $90.00 in a research note on Thursday, December 6th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the stock. The stock currently has an average rating of Buy and an average price target of $90.15.
Shares of NASDAQ:HQY traded down $1.57 during mid-day trading on Tuesday, reaching $54.46. The stock had a trading volume of 16,399 shares, compared to its average volume of 966,608. The company has a market capitalization of $3.36 billion, a P/E ratio of 101.15, a P/E/G ratio of 2.06 and a beta of 1.78. Healthequity has a 1 year low of $47.23 and a 1 year high of $101.58.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The company had revenue of $70.50 million for the quarter, compared to the consensus estimate of $69.60 million. Healthequity had a return on equity of 12.42% and a net margin of 24.52%. The firm’s revenue for the quarter was up 24.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.17 earnings per share. Equities research analysts predict that Healthequity will post 0.88 earnings per share for the current year.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction on Monday, October 22nd. The shares were sold at an average price of $87.01, for a total transaction of $348,040.00. Following the completion of the transaction, the vice president now directly owns 92,500 shares of the company’s stock, valued at approximately $8,048,425. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Frank Corvino sold 1,778 shares of the firm’s stock in a transaction dated Monday, December 10th. The shares were sold at an average price of $67.78, for a total transaction of $120,512.84. Following the transaction, the director now directly owns 5,051 shares in the company, valued at approximately $342,356.78. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,846 shares of company stock worth $1,163,748. Insiders own 4.00% of the company’s stock.
Several hedge funds have recently bought and sold shares of the stock. Retirement Systems of Alabama increased its position in Healthequity by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 133,268 shares of the company’s stock worth $7,949,000 after acquiring an additional 372 shares during the period. United Services Automobile Association boosted its stake in shares of Healthequity by 7.1% in the 2nd quarter. United Services Automobile Association now owns 8,298 shares of the company’s stock valued at $623,000 after purchasing an additional 548 shares in the last quarter. Hilltop Holdings Inc. boosted its stake in shares of Healthequity by 16.8% in the 2nd quarter. Hilltop Holdings Inc. now owns 4,868 shares of the company’s stock valued at $366,000 after purchasing an additional 700 shares in the last quarter. WINTON GROUP Ltd boosted its stake in shares of Healthequity by 15.7% in the 3rd quarter. WINTON GROUP Ltd now owns 5,274 shares of the company’s stock valued at $498,000 after purchasing an additional 717 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its stake in shares of Healthequity by 35.8% in the 3rd quarter. Advisors Asset Management Inc. now owns 2,901 shares of the company’s stock valued at $274,000 after purchasing an additional 765 shares in the last quarter. Institutional investors and hedge funds own 92.31% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: How to calculate the intrinsic value of a stock
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.